High-Risk Localized Soft Tissue Sarcoma
2 clinical trials · Condition
◉ Watch High-Risk Localized Soft Tissue Sarcoma
| Record | Firm | Date |
|---|---|---|
| The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma (NCT05774275) | Fudan University | 2022-08-25 |
| The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma (NCT05839275) | Fudan University | 2022-08-01 |
Track High-Risk Localized Soft Tissue Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.